Paxista (Nirmatrelvir 150mg/Ritonavir 100mg)
Paxista , a prescription drug that combines the antiviral drugs nirmatrelvir (150 mg) and Ritonavir (100 mg), is used to treat a variety of viral infections, particularly when it is a component of an all-encompassing treatment plan for human immunodeficiency virus (HIV) infection. This antiretroviral therapy’s dual action of stopping viral replication and halting the course of HIV-related illnesses makes it effective. Nirmatrelvir, a potent HIV-1 protease inhibitor, blocks the activity of the protease enzyme, which is required for the growth of mature virus particles. By inhibiting the enzyme protease, which prevents the virus from developing and multiplying, nirmatrelvir reduces the viral load in the body. It helps control infections and improves the immune system’s ability to fight viruses. Ritonavir is a component of Paxista, which increases the effectiveness of Nirmatrelvir. It performs as a pharmacokinetic enhancer or booster to increase the levels of Nirmatrelvir in the blood...